TNFSF14 and Miyoshi myopathy: Considering a higher proportion of light chain MM and IgD MM, and a generally later diagnosis in this geography, selinexor with dexamethasone emerges as an appealing treatment option for MM patients with moderate to severe renal dysfunction.